Back to News
Market Impact: 0.6

Leidos: Contract Wins, Improving Backlog, And A Reasonable Valuation

LDOSMCOSPGI
Company FundamentalsCorporate EarningsCorporate Guidance & OutlookCapital Returns (Dividends / Buybacks)M&A & RestructuringTechnology & InnovationInfrastructure & DefenseAnalyst Insights
Leidos: Contract Wins, Improving Backlog, And A Reasonable Valuation

Leidos (LDOS) delivered strong Q2'25 results, with non-GAAP EPS up 22% to a record $3.21 and adjusted EBITDA soaring 16% to $647 million, demonstrating significant margin expansion despite prior government efficiency concerns. The company's robust operational execution, 110% free cash flow conversion, strategic M&A (Kudu Dynamics), and share repurchases underscore its financial strength and capital allocation. Management raised full-year revenue and EBITDA margin guidance, projecting accelerated order intake driven by new legislation and a substantial $70 billion pipeline, positioning Leidos for continued growth and warranting a 'buy' rating despite a modest valuation premium.

Analysis

Leidos (LDOS) demonstrated significant operational resilience in its Q2’25 results, effectively countering earlier market concerns about government spending cuts. The company reported a 22% year-over-year increase in non-GAAP EPS to a record $3.21, driven by a substantial expansion in adjusted EBITDA margin to 15.2%, up from the prior year. This profitability improvement, aided by a one-time $25 million insurance reimbursement, was achieved despite a modest 3% revenue growth to $4.25 billion, which faced headwinds from contract award delays. The company's financial health is robust, underscored by $486 million in operating cash flow and a 110% free cash flow conversion rate. This strength facilitated aggressive capital allocation, including a $500 million accelerated share repurchase and the $291 million acquisition of Kudu Dynamics, which is already contributing to the sales pipeline. The balance sheet remains solid with a gross leverage ratio of just 2.2x. Critically, the backlog has stabilized, with a book-to-bill ratio of 0.9 recovering from the prior quarter, and a significant post-quarter contract win would have elevated this to 1.3. Management has raised its full-year guidance, lifting the midpoint of its revenue forecast and increasing its EBITDA margin outlook to the mid-13% range, signaling confidence in sustained operational discipline and an expected acceleration in orders in the second half of the year.